88 related articles for article (PubMed ID: 25051186)
1. Reactivity of kiteplatin with S-donor biomolecules and nucleotides.
Petruzzella E; Margiotta N; Natile G; Hoeschele JD
Dalton Trans; 2014 Sep; 43(34):12851-9. PubMed ID: 25051186
[TBL] [Abstract][Full Text] [Related]
2. DNA fragment conformations in adducts with Kiteplatin.
Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
[TBL] [Abstract][Full Text] [Related]
4. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
5. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine.
Strickmann DB; Kong A; Keppler BK
Electrophoresis; 2002 Jan; 23(1):74-80. PubMed ID: 11824623
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
7. Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA.
Kasparkova J; Kostrhunova H; Novohradsky V; Pracharova J; Curci A; Margiotta N; Natile G; Brabec V
Dalton Trans; 2017 Oct; 46(41):14139-14148. PubMed ID: 28972623
[TBL] [Abstract][Full Text] [Related]
8. Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands.
Jovanović S; Petrović B; Bugarčić ŽD; van Eldik R
Dalton Trans; 2013 Jun; 42(24):8890-6. PubMed ID: 23657491
[TBL] [Abstract][Full Text] [Related]
9. Effect of thioethers on DNA platination by trans-platinum complexes.
Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
[TBL] [Abstract][Full Text] [Related]
10. Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione.
Shoeib T; Sharp BL
Metallomics; 2012 Dec; 4(12):1308-20. PubMed ID: 23128601
[TBL] [Abstract][Full Text] [Related]
11. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
12. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
[TBL] [Abstract][Full Text] [Related]
13. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
Margiotta N; Savino S; Gandin V; Marzano C; Natile G
ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
[TBL] [Abstract][Full Text] [Related]
14. Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy.
Curci A; Gandin V; Marzano C; Hoeschele JD; Natile G; Margiotta N
Inorg Chem; 2017 Jul; 56(13):7482-7493. PubMed ID: 28636387
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of a cis-dichloridoplatinum(ii) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathione.
Karmakar S; Purkait K; Chatterjee S; Mukherjee A
Dalton Trans; 2016 Feb; 45(8):3599-615. PubMed ID: 26810988
[TBL] [Abstract][Full Text] [Related]
16. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
17. EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.
Provost K; Bouvet-Muller D; Crauste-Manciet S; Moscovici J; Olivi L; Vlaic G; Michalowicz A
Biochimie; 2009 Oct; 91(10):1301-6. PubMed ID: 19607872
[TBL] [Abstract][Full Text] [Related]
18. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
Mauldin SK; Gibbons G; Wyrick SD; Chaney SG
Cancer Res; 1988 Sep; 48(18):5136-44. PubMed ID: 3409241
[TBL] [Abstract][Full Text] [Related]
19. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
20. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
